GENEVA, Aug. 21 -- SIGNPATH PHARMA INC. filed a patent application (US2026/014270) for “LIPOSOMAL CURCUMIN AND STANDARD RADIATION AND TEMOZOLOMIDE FOR TREATMENT OF HIGH-GRADE GLIOMAS”. With publication no. WO/2026/173816, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 31/12
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....